A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor

NCT00001696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Cancer

Interventions

DRUG: Genistein

Sponsor

National Cancer Institute (NCI)